Chien‐Chia Chuang

509 total citations
25 papers, 335 citations indexed

About

Chien‐Chia Chuang is a scholar working on Immunology and Allergy, Dermatology and Physiology. According to data from OpenAlex, Chien‐Chia Chuang has authored 25 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology and Allergy, 14 papers in Dermatology and 10 papers in Physiology. Recurrent topics in Chien‐Chia Chuang's work include Allergic Rhinitis and Sensitization (17 papers), Dermatology and Skin Diseases (14 papers) and Asthma and respiratory diseases (10 papers). Chien‐Chia Chuang is often cited by papers focused on Allergic Rhinitis and Sensitization (17 papers), Dermatology and Skin Diseases (14 papers) and Asthma and respiratory diseases (10 papers). Chien‐Chia Chuang collaborates with scholars based in United States, France and United Kingdom. Chien‐Chia Chuang's co-authors include Siddhesh Kamat, Leda Mannent, Jérôme Msihid, Claus Bachert, Peter W. Hellings, Enrico Heffler, Anju T. Peters, Joseph K. Han, Isabelle Guillemin and Asif Khan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Journal of Investigative Dermatology.

In The Last Decade

Chien‐Chia Chuang

24 papers receiving 330 citations

Peers

Countries citing papers authored by Chien‐Chia Chuang

Since Specialization

Citations

This map shows the geographic impact of Chien‐Chia Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Chia Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Chia Chuang more than expected).

Fields of papers citing papers by Chien‐Chia Chuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Chia Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Chia Chuang. The network helps show where Chien‐Chia Chuang may publish in the future.

Co-authorship network of co-authors of Chien‐Chia Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Chia Chuang. A scholar is included among the top collaborators of Chien‐Chia Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Chia Chuang. Chien‐Chia Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiology and Burden of Pediatric Atopic Dermatitis in China 2025 ·Dermatology and Therapy ·Chien‐Chia Chuang, (unknown), Ryan M. Thomas, (unknown)	1
2	The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic Dermatitis 2024 ·Dermatology and Therapy ·Chien‐Chia Chuang, David M. Pariser, Eric L. Simpson, Jennifer Dine, T. Michelle Brown, Sheri Fehnel, Zhixiao Wang	1
3	Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial 2023 ·Journal of Asthma and Allergy ·Jorge Máspero, Asif Khan, Carl Philpott, Peter W. Hellings, Claire Hopkins, Martin Wagenmann, Shahid Siddiqui, Jérôme Msihid, Scott D. Nash, Chien‐Chia Chuang, Siddhesh Kamat, Paul J. Rowe, Yamo Deniz, Juby A. Jacob‐Nara	9
4	Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps 2023 ·Clinical & Translational Immunology ·Philippe Gevaert, Stella E. Lee, Russell A. Settipane, Martin Wagenmann, Jérôme Msihid, Shahid Siddiqui, Scott D. Nash, Juby A. Jacob‐Nara, Asif Khan, Siddhesh Kamat, Chien‐Chia Chuang	7
5	Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family 2023 ·SHILAP Revista de lepidopterología ·Amy S. Paller, S.E. Marrón, Diane Whalley, Lauren Nelson, Shanshan Qin, Jingdong Chao, Ashish Bansal, Chien‐Chia Chuang, Zhixiao Wang	1
6	Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial 2023 ·American Journal of Clinical Dermatology ·Elaine C. Siegfried, Michael J. Cork, Norito Katoh, Haixin Zhang, Chien‐Chia Chuang, (unknown), Ana B. Rossi, Sonya Cyr, Annie Zhang	8
7	Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey) 2023 ·Dermatology and Therapy ·Amy S. Paller, Stephan Weidinger, Korey Capozza, Andrew Pink, Mark Boon Yang Tang, Xavier Guillaume, Amy Praestgaard, (unknown), Chien‐Chia Chuang, (unknown), Randy Prescilla	7
8	Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study 2023 ·Dermatology and Therapy ·Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien‐Chia Chuang, Zhixiao Wang, (unknown), Bruno Martins, Eric Q. Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober	11
9	Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies 2022 ·Clinical & Experimental Allergy ·Claus Bachert, Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Chien‐Chia Chuang, R. Rout, (unknown), (unknown), Juby A. Jacob‐Nara, Paul J. Rowe, Yamo Deniz, Zhen Chen, Siddhesh Kamat, Shahid Siddiqui	9
10	Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies 2022 ·Allergy ·Stella E. Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda Mannent, Yongtao Li, Shahid Siddiqui, Chien‐Chia Chuang, Siddhesh Kamat, Asif Khan	40
11	Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE) 2022 ·American Journal of Clinical Dermatology ·Andrew Blauvelt, Emma Guttman‐Yassky, Amy S. Paller, Eric L. Simpson, Michael J. Cork, Jamie Weisman, John Browning, Weily Soong, Xian Sun, Zhen Chen, Matthew P. Kosloski, Mohamed Kamal, Dimittri Delevry, Chien‐Chia Chuang, John T. O’Malley, Ashish Bansal	62
12	Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis 2022 ·Dermatology and Therapy ·Amy S. Paller, Gil Yosipovitch, Stephan Weidinger, Dana DiBenedetti, Diane Whalley, Abhijit Gadkari, Isabelle Guillemin, Haixin Zhang, Laurent Eckert, Jingdong Chao, Ashish Bansal, Chien‐Chia Chuang, Dimittri Delevry	4
13	147 Development and validation of a caregiver-reported numeric rating scale for measuring pruritus in children aged 6 months to <6 years with atopic dermatitis 2022 ·Journal of Investigative Dermatology ·Amy S. Paller, Elaine C. Siegfried, S.E. Marrón, M. Clark, Dana DiBenedetti, Lauren Nelson, J. Chao, Ashish Bansal, Yiping Sun, Chien‐Chia Chuang, Zhenxun Wang	1
14	Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis 2022 ·ClinicoEconomics and Outcomes Research ·Wenzhen Ge, (unknown), Chien‐Chia Chuang, Yongtao Li, R. Rout, Shahid Siddiqui, Siddhesh Kamat	4
15	32929 Dupilumab decreases concomitant therapy use in adults with atopic dermatitis (AD): Long-term data from the RELIEVE-AD study 2022 ·Journal of the American Academy of Dermatology ·Dimittri Delevry, Jingdong Chao, Chien‐Chia Chuang	1
16	33322 Dupilumab improves patient-reported outcomes among adults with moderate-to-severe atopic dermatitis (AD) in clinical practice: 30-36 month results from the RELIEVE-AD study 2022 ·Journal of the American Academy of Dermatology ·Bruce Strober, Jingdong Chao, Chien‐Chia Chuang, Min Yang, Brad Shumel, Jessie Wang, (unknown), Debra Sierka, Zhixiao Wang, Dimittri Delevry	0
17	Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial 2021 ·Journal of Allergy and Clinical Immunology ·Jorge Máspero, Carl Philpott, Peter W. Hellings, Claire Hopkins, Martin Wagenmann, Shahid Siddiqui, Juby A. Jacob‐Nara, Jérôme Msihid, Chien‐Chia Chuang, Siddhesh Kamat, Asif Khan	1
18	Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Anju T. Peters, Joseph K. Han, Peter W. Hellings, Enrico Heffler, Philippe Gevaert, Claus Bachert, Yingxin Xu, Chien‐Chia Chuang, Binod Neupane, Jérôme Msihid, Leda Mannent, Patricia Guyot, Siddhesh Kamat	73
19	Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension 2017 ·CNS Spectrums ·Joseph F. Goldberg, Daisy Ng‐Mak, Cynthia Siu, Chien‐Chia Chuang, Krithika Rajagopalan, Antony Loebel	9
20	Tumor Necrosis Factor-Blocker Dose Escalation in Rheumatoid Arthritis Patients in a Pharmacy Benefit Management Setting 2013 ·Advances in Therapy ·Steven W. Blume, Kathleen M. Fox, George Joseph, Chien‐Chia Chuang, (unknown), Shravanthi R. Gandra	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact